Galderma Investigational Site

Augsburg 86179

0 studies enrolling now · 3 studies all time

What they study most

Acne Vulgaris, Prurigo Nodularis

Studies at this site

• A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Running, not enrolling
• Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris — Completed